The present invention relates to methods and compounds for causing BRM
re-expression in cells, such as cancer cells, that have lost BRM
expression. In particular, the present invention relates to screening
methods for identifying BRM expression-promoting compounds. The present
invention also relates to methods of accessing cancer risk through the
identification of polymorphisms in the BRM promoter.